Carvedilol in patients with chronic heart failure clinical observation
Zhang Jing
Abstract
Zhang Jing
Abstract
Objective:Carvedilol in chronic heart failure.Methods:Patients with chronic heart failure patients,in accordance with New York Heart Association(NYHA) heart function classification standards group,randomly divided into treatment group(40 cases) and carvedilol treatment group(40 cases),the former application of vasodilators,diuretics,ACEI,and cardiac drugs to correct heart failure,correct the failure of conventional treatment of the latter based on the combination of carvedilol,groups 6 months after treatment by echocardiography left ventricular ejection fraction(LVEF),left ventricular end systolic diameter(LVESD),left ventricular end diastolic diameter(LVEDD),and 6min walking test measured(6-MWT).Results:In the conventional treatment of heart failure based on the correct application of carvedilol,LVEF increased significantly,LVESD,LVEDD significantly decreased,6-MWT significantly improved heart function improved significantly better than the conventional treatment group(P0.05).Conclusion:During routine clinical treatment of chronic heart failure carvedilol in combination,Hemodynamic abnormality can be corrected,Improve exercise tolerance,Improve heart function.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:Carvedilol in chronic heart failure.Methods:Patients with chronic heart failure patients,in accordance with New York Heart Association(NYHA) heart function classification standards group,randomly divided into treatment group(40 cases) and carvedilol treatment group(40 cases),the former application of vasodilators,diuretics,ACEI,and cardiac drugs to correct heart failure,correct the failure of conventional treatment of the latter based on the combination of carvedilol,groups 6 months after treatment by echocardiography left ventricular ejection fraction(LVEF),left ventricular end systolic diameter(LVESD),left ventricular end diastolic diameter(LVEDD),and 6min walking test measured(6-MWT).Results:In the conventional treatment of heart failure based on the correct application of carvedilol,LVEF increased significantly,LVESD,LVEDD significantly decreased,6-MWT significantly improved heart function improved significantly better than the conventional treatment group(P0.05).Conclusion:During routine clinical treatment of chronic heart failure carvedilol in combination,Hemodynamic abnormality can be corrected,Improve exercise tolerance,Improve heart function.
Key concepts: Carvedilol, Ejection fraction, Heart failure, Medicine, Cardiology, Internal medicine, Diastole, Vasodilation